ÇEŞİTLİ YÖNLERİ İLE PUFALAR VE PERİODONTİTİS İLE İLİŞKİLERİ

Yıl 2024, Cilt: 2 Sayı: 1, 30 - 46, 30.06.2024

Ayşegül Sunar , Ali Hakan Develioğlu

Öz

Klinik olarak periodontitis, ataşman kaybı, periodontal cep, diş eti kanaması ve kemik rezorpsiyonu ile kendini göstermektedir. Bu belirtiler radyografik olarak gözlenmekte ve potansiyel olarak diş kaybına yol açabilimektedir. Dokosaheksaenoik asit (DHA) ve eikosapentaenoik asit (EPA) gibi Omega-3 çoklu doymamış yağ asitleri (ω-3 yağ asitleri, PUFA); romatoid artrit, ülseratif kolit, ateroskleroz, kanser, kalp ve damar hastalıkları ve periodontitis üzerinde antiinflamatuar, koruyucu ve tedavi edici etkilere sahiptir. Bu yağ asitleri ince bağırsakta emilir ve kan dolaşımı yoluyla çeşitli dokulara taşınır. Yağ dokusu fazla yağ asitlerini depolar ve gerektiğinde bunları harekete geçirebilir. Bu süreç, özellikle iltihaplanmanın merkezi bir rol oynadığı periodontal sağlık bağlamında, bu yağ asitlerinin yararlı etkilerini sürdürmek için tutarlı alım gerekliliğinin altını çizmektedir. Bu derlemede, Omega 3 çoklu yağ asitlerinin periodontitis ile ilişkileri incelenmiş olup Omega 3 PUFA’ların kullanıldığı klinik ve deneysel çalışmalar değerlendirilerek bulgular sentezlenmiştir.

Anahtar Kelimeler

Yağ Asitleri, Omega-3, n-3 PUFA, Periodontitis

Kaynakça

• 1. Van Dyke, T. E., Bartold, P. M., & Reynolds, E. C. (2020). The Nexus Between Periodontal Inflammation and Dysbiosis. Frontiers in Immunology, 11, 511. https://doi.org/10.3389/fimmu.2020.00511
• 2. Socransky, S. S., Haffajee, A. D., Cugini, M. A., Smith, C., & Kent, R. L., Jr (1998). Microbial complexes in subgingival plaque. Journal of Clinical Periodontology, 25(2), 134–144. https://doi.org/10.1111/j.1600-051x.1998.tb02419.x
• 3. Sedghi, L. M., Bacino, M., & Kapila, Y. L. (2021). Periodontal Disease: The Good, The Bad, and The Unknown. Frontiers in Cellular and Infection Microbiology, 11, 766944. https://doi.org/10.3389/fcimb.2021.766944
• 4. Genco, R. J., & Sanz, M. (2020). Clinical and public health implications of periodontal and systemic diseases: An overview. Periodontology 2000, 83(1), 7–13. https://doi.org/10.1111/prd.12344
• 5. de Souza, A. B., Okawa, R. T., Silva, C. O., & Araújo, M. G. (2017). Short-term changes on C-reactive protein (CRP) levels after non-surgical periodontal treatment in systemically healthy individuals. Clinical Oral Investigations, 21(1), 477–484. https://doi.org/10.1007/s00784-016-1817-0
• 6. Shimada, Y., Komatsu, Y., Ikezawa-Suzuki, I., Tai, H., Sugita, N., & Yoshie, H. (2010). The effect of periodontal treatment on serum leptin, interleukin-6, and C-reactive protein. Journal of Periodontology, 81(8), 1118–1123. https://doi.org/10.1902/jop.2010.090741
• 7. Fullerton, J. N., & Gilroy, D. W. (2016). Resolution of inflammation: a new therapeutic frontier. Nature Reviews Drug Discovery, 15(8), 551–567. https://doi.org/10.1038/nrd.2016.39
• 8. Van Dyke T. E. (2017). Pro-resolving mediators in the regulation of periodontal disease. Molecular Aspects of Medicine, 58, 21–36. https://doi.org/10.1016/j.mam.2017.04.006
• 9. Chiang, N., Fredman, G., Bäckhed, F., Oh, S. F., Vickery, T., Schmidt, B. A., & Serhan, C. N. (2012). Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature, 484(7395), 524–528. https://doi.org/10.1038/nature11042
• 10. Serhan, C.N., Sulciner, M.L. (2023). Resolution medicine in cancer, infection, pain and inflammation: are we on track to address the next Pandemic?. Cancer Metastasis Rev 42, 13-17. https://doi.org/10.1007/s10555-023-10091-5
• 11. Osorio Parra, M. M., Elangovan, S., & Lee, C. T. (2019). Specialized pro-resolving lipid mediators in experimental periodontitis: A systematic review. Oral Diseases, 25(5), 1265–1276. https://doi.org/10.1111/odi.12979
• 12. Rakian, A., Rakian, R., Shay, A. E., Serhan, C. N., & Van Dyke, T. E. (2022). Periodontal Stem Cells Synthesize Maresin Conjugate in Tissue Regeneration 3. Journal of Dental Research, 101(10), 1205–1213. https://doi.org/10.1177/00220345221090879
• 13. Serhan, C. N., & Chiang, N. (2023). Resolvins and cysteinyl-containing pro-resolving mediators activate resolution of infectious inflammation and tissue regeneration. Prostaglandins & Other Lipid Mediators, 166, 106718. https://doi.org/10.1016/j.prostaglandins.2023.106718
• 14. Serhan, C. N., Chiang, N., & Dalli, J. (2015). The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution. Seminars in Immunology, 27(3), 200–215. https://doi.org/10.1016/j.smim.2015.03.004
• 15. Lee, C. T., Teles, R., Kantarci, A., Chen, T., McCafferty, J., Starr, J. R., Brito, L. C., Paster, B. J., & Van Dyke, T. E. (2016). Resolvin E1 Reverses Experimental Periodontitis and Dysbiosis. Journal of Immunology (Baltimore, Md.: 1950), 197(7), 2796–2806. https://doi.org/10.4049/jimmunol.1600859
• 16. Alvarez, C., Abdalla, H., Sulliman, S., Rojas, P., Wu, Y. C., Almarhoumi, R., Huang, R. Y., Galindo, M., Vernal, R., & Kantarci, A. (2021). RvE1 Impacts the Gingival Inflammatory Infiltrate by Inhibiting the T Cell Response in Experimental Periodontitis. Frontiers in Immunology, 12, 664756. https://doi.org/10.3389/fimmu.2021.664756
• 17. Zarrough AE, Hasturk H, Stephens DN, Dyke TEV, Kantarci A. (2023). Resolvin D1 modulates periodontal ligament fibroblast function. Journal of Periodontology, 94(5), 683–93. doi: 10.1002/JPER.22-0462
• 18. Albuquerque-Souza, E., Schulte, F., Chen, T., Hardt, M., Hasturk, H., Van Dyke, T. E., Holzhausen, M., & Kantarci, A. (2020). Maresin-1 and Resolvin E1 Promote Regenerative Properties of Periodontal Ligament Stem Cells Under Inflammatory Conditions. Frontiers in Immunology, 11, 585530. https://doi.org/10.3389/fimmu.2020.585530
• 19. Hasturk, H., Schulte, F., Martins, M., Sherzai, H., Floros, C., Cugini, M., Chiu, C. J., Hardt, M., & Van Dyke, T. (2021). Safety and Preliminary Efficacy of a Novel Host-Modulatory Therapy for Reducing Gingival Inflammation. Frontiers in Immunology, 12, 704163. https://doi.org/10.3389/fimmu.2021.704163
• 20. Wang, C. W., Colas, R. A., Dalli, J., Arnardottir, H. H., Nguyen, D., Hasturk, H., Chiang, N., Van Dyke, T. E., & Serhan, C. N. (2015). Maresin 1 Biosynthesis and Proresolving Anti-infective Functions with Human-Localized Aggressive Periodontitis Leukocytes. Infection and Immunity, 84(3), 658–665.https://doi.org/10.1128/IAI.01131-15
• 21. Van Dyke, T. E., Hasturk, H., Kantarci, A., Freire, M. O., Nguyen, D., Dalli, J., & Serhan, C. N. (2015). Proresolving nanomedicines activate bone regeneration in periodontitis. Journal of Dental Research, 94(1), 148–156. https://doi.org/10.1177/0022034514557331
• 22. Basil, M. C., & Levy, B. D. (2016). Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nature Reviews Immunology, 16(1), 51–67. https://doi.org/10.1038/nri.2015.4
• 23. Wang, R. X., Colgan, S., P. (2017). Special pro-resolving mediator (SPM) actions in regulating gastro-intestinal inflammation and gut mucosal immune responses. Mol Aspects Medicine 58, 93–101. doi: 10.1016/j.mam.2017.02.002
• 24. Spite, M., Clària, J., & Serhan, C. N. (2014). Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metabolism, 19(1), 21–36. https://doi.org/10.1016/j.cmet.2013.10.006
• 25. Elabdeen, H. R., Mustafa, M., Szklenar, M., Rühl, R., Ali, R., & Bolstad, A. I. (2013). Ratio of pro-resolving and pro-inflammatory lipid mediator precursors as potential markers for aggressive periodontitis. PloS one, 8(8), e70838. https://doi.org/10.1371/journal.pone.0070838
• 26. Tobón-Arroyave, S. I., Isaza-Guzmán, D. M., Gómez-Ortega, J., & Flórez-Alzate, A. A. (2019). Salivary levels of specialized pro-resolving lipid mediators as indicators of periodontal health/disease status. Journal of Clinical Periodontology, 46(10), 978–990. https://doi.org/10.1111/jcpe.13173
• 26. Colas, R. A., Shinohara, M., Dalli, J., Chiang, N., & Serhan, C. N. (2014). Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. American Journal of Physiology. Cell Physiology, 307(1), C39–C54. https://doi.org/10.1152/ajpcell.00024.2014
• 27. Ferguson, B., Bokka, N. R., Maddipati, K. R., Ayilavarapu, S., Weltman, R., Zhu, L., Chen, W., Zheng, W. J., Angelov, N., Van Dyke, T. E., & Lee, C. T. (2020). Distinct Profiles of Specialized Pro-resolving Lipid Mediators and Corresponding Receptor Gene Expression in Periodontal Inflammation. Frontiers in Immunology, 11, 1307. https://doi.org/10.3389/fimmu.2020.01307
• 28. Calder P. C. (2013). Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? British Journal of Clinical Pharmacology, 75(3), 645–662. https://doi.org/10.1111/j.1365-2125.2012.04374.x
• 29. Costantini, L., Molinari, R., Farinon, B., & Merendino, N. (2017). Impact of Omega-3 Fatty Acids on the Gut Microbiota. International Journal of Molecular Sciences, 18(12), 2645. https://doi.org/10.3390/ijms18122645
• 30. Brown, E. M., Clardy, J., & Xavier, R. J. (2023). Gut microbiome lipid metabolism and its impact on host physiology. Cell Host & Microbe, 31(2), 173–186. https://doi.org/10.1016/j.chom.2023.01.009
• 31. Huang, C. B., & Ebersole, J. L. (2010). A novel bioactivity of omega-3 polyunsaturated fatty acids and their ester derivatives. Molecular oral Microbiology, 25(1), 75–80. https://doi.org/10.1111/j.2041-1014.2009.00553.x
• 32. Sun, M., Zhou, Z., Dong, J., Zhang, J., Xia, Y., & Shu, R. (2016). Antibacterial and antibiofilm activities of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) against periodontopathic bacteria. Microbial Pathogenesis, 99, 196–203. https://doi.org/10.1016/j.micpath.2016.08.025
• 33. Stańdo-Retecka, M., Piatek, P., Namiecinska, M., Bonikowski, R., Lewkowicz, P., & Lewkowicz, N. (2023). Clinical and microbiological outcomes of subgingival instrumentation supplemented with high-dose omega-3 polyunsaturated fatty acids in periodontal treatment - a randomized clinical trial. BMC Oral Health, 23(1), 290. https://doi.org/10.1186/s12903-023-03018-7
• 34. Park, S. Y., Hwang, B. O., Lim, M., Ok, S. H., Lee, S. K., Chun, K. S., Park, K. K., Hu, Y., Chung, W. Y., & Song, N. Y. (2021). Oral-Gut Microbiome Axis in Gastrointestinal Disease and Cancer. Cancers, 13(9), 2124. https://doi.org/10.3390/cancers13092124
• 35. Olsen, I., & Yamazaki, K. (2019). Can oral bacteria affect the microbiome of the gut? Journal of Oral Microbiology, 11(1), 1586422. https://doi.org/10.1080/20002297.2019.1586422
• 36. Yates, C. M., Calder, P. C., & Ed Rainger, G. (2014). Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease. Pharmacology & Therapeutics, 141(3), 272–282. https://doi.org/10.1016/j.pharmthera.2013.10.010
• 37. Schunck, W. H., Konkel, A., Fischer, R., & Weylandt, K. H. (2018). Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases. Pharmacology & Therapeutics, 183, 177–204. https://doi.org/10.1016/j.pharmthera.2017.10.016
• 38. Keskiner, I., Saygun, I., Bal, V., Serdar, M., & Kantarci, A. (2017). Dietary supplementation with low-dose omega-3 fatty acids reduces salivary tumor necrosis factor-α levels in patients with chronic periodontitis: a randomized controlled clinical study. Journal of Periodontal Research, 52(4), 695–703. https://doi.org/10.1111/jre.12434
• 39. Colussi, G., Catena, C., Novello, M., Bertin, N., & Sechi, L. A. (2017). Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: Relevance for cardiovascular outcomes. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD, 27(3), 191–200. https://doi.org/10.1016/j.numecd.2016.07.011
• 40. Hussain, S. B., Leira, Y., Zehra, S. A., Botelho, J., Machado, V., Ciurtin, C., D'Aiuto, F., & Orlandi, M. (2022). Periodontitis and Systemic Lupus Erythematosus: A systematic reviewand meta-analysis. Journal of Periodontal Research, 57(1), 1–10. https://doi.org/10.1111/jre.12936
• 41. Barnawi, B. M., Alrashidi, N. S., Albalawi, A. M., Alakeel, N. S., Hamed, J. T., Barashid, A. A., Alduraibi, M. S., Alhussain, G. S., Alghadeer, J. Y., Alarifi, N. A., & Altalhi, A. M. (2023). Nutritional Modulation of Periodontal Diseases: A Narrative Review of Recent Evidence. Cureus, 15(12), e50200. https://doi.org/10.7759/cureus.50200
• 42. Woelber, J. P., Gärtner, M., Breuninger, L., Anderson, A., König, D., Hellwig, E., Al-Ahmad, A., Vach, K., Dötsch, A., Ratka-Krüger, P., & Tennert, C. (2019). The influence of an anti-inflammatory diet on gingivitis. A randomized controlled trial. Journal of Clinical Periodontology, 46(4), 481–490. https://doi.org/10.1111/jcpe.13094
• 43. Chatterjee, D., Chatterjee, A., Kalra, D., Kapoor, A., Vijay, S., & Jain, S. (2022). Role of adjunct use of omega 3 fatty acids in periodontal therapy of periodontitis. A systematic review and meta-analysis. Journal of Oral Biology and Craniofacial Research, 12(1), 55–62. https://doi.org/10.1016/j.jobcr.2021.10.005
• 44. Sanz, M., Herrera, D., Kebschull, M., Chapple, I., Jepsen, S., Beglundh, T., Sculean, A., Tonetti, M. S., & EFP Workshop Participants and Methodological Consultants (2020). Treatment of stage I-III periodontitis-The EFP S3 level clinical practice guideline. Journal of Clinical Periodontology, 47 Suppl 22, 4–60. https://doi.org/10.1111/jcpe.13290.
• 45. Azuma, M. M., Cardoso, C. B. M., da Silva, C. C., de Oliveira, P. H. C., Jacinto, R. C., Andrada, A. C., & Cintra, L. T. A. (2022). The use of omega-3 fatty acids in the treatment of oral diseases. Oral Diseases, 28(2), 264–274. https://doi.org/10.1111/odi.13667
• 46. Stańdo, M., Piatek, P., Namiecinska, M., Lewkowicz, P., & Lewkowicz, N. (2020). Omega-3 Polyunsaturated Fatty Acids EPA and DHA as an Adjunct to Non-Surgical Treatment of Periodontitis: A Randomized Clinical Trial. Nutrients, 12(9), 2614. https://doi.org/10.3390/nu12092614
• 47. Azuma, M. M., Gomes-Filho, J. E., Cardoso, C. B. M., Pipa, C. B., Narciso, L. G., Bomfim, S. R. M., Jacinto, R. C., & Cintra, L. T. A. (2018). Omega 3 Fatty Acids Reduce the Triglyceride Levels in Rats with Apical Periodontitis. Brazilian Dental Journal, 29(2), 173–178. https://doi.org/10.1590/0103-6440201801702
• 48. González-Alva, P., Solís-Suárez, D. L., Cifuentes-Mendiola, S. E., & García-Hernández, A. L. (2024). A diet rich in omega-3 fatty acid improves periodontitis and tissue destruction byMMP2- and MMP9-linked inflammation in a murine model. Odontology, 112(1), 185–199. https://doi.org/10.1007/s10266-023-00831-y
• 49. Elgendy, E. A., & Kazem, H. H. (2018). Effect of Omega-3 Fatty Acids on Chronic Periodontitis Patients in Postmenopausal Women: A Randomised Controlled Clinical Study. Oral Health & Preventive Dentistry, 16(4), 327–332. https://doi.org/10.3290/j.ohpd.a40957
• 50. Van Ravensteijn, M. M., Timmerman,M. F., Brouwer, E. A. G., & Slot, D. E. (2022). The effect of omega-3 fatty acids on active periodontal therapy: Asystematic review and meta-analysis. Journal of Clinical Periodontology, 49(10), 1024–1037. https://doi.org/10.1111/jcpe.13680VAN RAVENSTEIJNET AL.1037
• 51. Smiley, C. J., Tracy, S. L., Abt, E., Michalowicz, B. S., John, M. T., Gunsolley, J., Cobb, C. M., Rossmann, J., Harrel, S. K., Forrest, J. L., Hujoel, P. P., Noraian, K. W., Greenwell, H., Frantsve-Hawley, J., Estrich, C., & Hanson, N. (2015). Systematic review and meta-analysis on the nonsurgical treatment of chronic periodontitis by means of scaling and root planing with or without adjuncts. Journal of the American Dental Association (1939), 146(7), 508–24.e5. https://doi.org/10.1016/j.adaj.2015.01.028